SANOFI-ADR (SNY) Stock Fundamental Analysis

NASDAQ:SNY • US80105N1054

46.14 USD
-0.29 (-0.62%)
At close: Feb 18, 2026
46.14 USD
0 (0%)
After Hours: 2/18/2026, 4:56:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SNY. SNY was compared to 191 industry peers in the Pharmaceuticals industry. While SNY has a great profitability rating, there are quite some concerns on its financial health. SNY is not valued too expensively and it also shows a decent growth rate. Finally SNY also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • SNY had positive earnings in the past year.
  • In the past 5 years SNY has always been profitable.
  • Each year in the past 5 years SNY had a positive operating cash flow.
SNY Yearly Net Income VS EBIT VS OCF VS FCFSNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SNY has a better Return On Assets (10.63%) than 92.15% of its industry peers.
  • SNY has a Return On Equity of 18.84%. This is amongst the best in the industry. SNY outperforms 90.05% of its industry peers.
  • The Return On Invested Capital of SNY (13.35%) is better than 93.19% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SNY is significantly below the industry average of 12.64%.
  • The last Return On Invested Capital (13.35%) for SNY is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SNY Yearly ROA, ROE, ROICSNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • SNY has a better Profit Margin (20.63%) than 91.10% of its industry peers.
  • SNY's Profit Margin has declined in the last couple of years.
  • SNY's Operating Margin of 23.61% is amongst the best of the industry. SNY outperforms 90.58% of its industry peers.
  • In the last couple of years the Operating Margin of SNY has grown nicely.
  • SNY has a better Gross Margin (72.29%) than 79.58% of its industry peers.
  • In the last couple of years the Gross Margin of SNY has remained more or less at the same level.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SNY Yearly Profit, Operating, Gross MarginsSNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • SNY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • SNY has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SNY has been reduced compared to 5 years ago.
  • SNY has a worse debt/assets ratio than last year.
SNY Yearly Shares OutstandingSNY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
SNY Yearly Total Debt VS Total AssetsSNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SNY has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • SNY has a Debt to Equity ratio of 0.18. This is comparable to the rest of the industry: SNY outperforms 44.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.7
WACC7.86%
SNY Yearly LT Debt VS Equity VS FCFSNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • SNY has a Current Ratio of 1.06. This is a normal value and indicates that SNY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of SNY (1.06) is worse than 83.77% of its industry peers.
  • A Quick Ratio of 0.30 indicates that SNY may have some problems paying its short term obligations.
  • The Quick ratio of SNY (0.30) is worse than 91.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
SNY Yearly Current Assets VS Current LiabilitesSNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.82% over the past year.
  • SNY shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.58% yearly.
  • The Revenue has been growing slightly by 5.49% in the past year.
  • SNY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.57% yearly.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.70% on average over the next years.
  • The Revenue is expected to grow by 4.86% on average over the next years.
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SNY Yearly Revenue VS EstimatesSNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SNY Yearly EPS VS EstimatesSNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • SNY is valuated reasonably with a Price/Earnings ratio of 9.90.
  • 92.15% of the companies in the same industry are more expensive than SNY, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.16. SNY is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 9.15, the valuation of SNY can be described as very reasonable.
  • SNY's Price/Forward Earnings ratio is rather cheap when compared to the industry. SNY is cheaper than 89.01% of the companies in the same industry.
  • SNY is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.9
Fwd PE 9.15
SNY Price Earnings VS Forward Price EarningsSNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNY Per share dataSNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • SNY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • SNY has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.22
PEG (5Y)1.77
EPS Next 2Y6.92%
EPS Next 3Y8.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 5.21%, SNY is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.18, SNY pays a better dividend. On top of this SNY pays more dividend than 97.38% of the companies listed in the same industry.
  • SNY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 5.21%

5.2 History

  • The dividend of SNY has a limited annual growth rate of 4.30%.
  • SNY has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of SNY decreased in the last 3 years.
Dividend Growth(5Y)4.3%
Div Incr Years2
Div Non Decr Years2
SNY Yearly Dividends per shareSNY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • SNY pays out 34.36% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of SNY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.36%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
SNY Yearly Income VS Free CF VS DividendSNY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
SNY Dividend Payout.SNY Dividend Payout, showing the Payout Ratio.SNY Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI-ADR

NASDAQ:SNY (2/18/2026, 4:56:00 PM)

After market: 46.14 0 (0%)

46.14

-0.29 (-0.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner Change-0.39%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap111.44B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts77.33
Price Target58.84 (27.52%)
Short Float %0.39%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield 5.21%
Yearly Dividend2.26
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)3
Avg Revenue beat(12)8.5%
Revenue beat(16)7
Avg Revenue beat(16)20.74%
PT rev (1m)-5.49%
PT rev (3m)-4.88%
EPS NQ rev (1m)3.69%
EPS NQ rev (3m)3.22%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)-0.73%
Revenue NQ rev (1m)1.41%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 9.9
Fwd PE 9.15
P/S 1.41
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB 21.44
EV/EBITDA N/A
EPS(TTM)4.66
EY10.1%
EPS(NY)5.04
Fwd EY10.93%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.76
BVpS35.87
TBVpS2.15
PEG (NY)1.22
PEG (5Y)1.77
Graham Number61.33
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.86%
ROIC/WACC1.7
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y7.52%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI-ADR / SNY FAQ

What is the fundamental rating for SNY stock?

ChartMill assigns a fundamental rating of 5 / 10 to SNY.


Can you provide the valuation status for SANOFI-ADR?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI-ADR (SNY). This can be considered as Fairly Valued.


How profitable is SANOFI-ADR (SNY) stock?

SANOFI-ADR (SNY) has a profitability rating of 8 / 10.


What are the PE and PB ratios of SANOFI-ADR (SNY) stock?

The Price/Earnings (PE) ratio for SANOFI-ADR (SNY) is 9.9 and the Price/Book (PB) ratio is 1.29.


How sustainable is the dividend of SANOFI-ADR (SNY) stock?

The dividend rating of SANOFI-ADR (SNY) is 8 / 10 and the dividend payout ratio is 34.36%.